PDX Portal

Model Details

Patient Information for Model: BCM-PDAC-28

Model Contact

Model: BCM-PDAC-28
Model Contact: Qizhi Cathy Yao
Institution: BCM Pancreas PDX Program
Email: qizhiyao@bcm.edu

Patient Information

Clinical Timeline

Clinical Information at Collection

Clinical Biomarkers/Mutations at Collection

Pathology Information at Collection

Model Information for Model: BCM-PDAC-28

Model Details - Initial Implantation of Patient Tissue

Mutations (Cancer Gene Census List)

Mutation data is currently not available.

CNV

Histology Information for Model: BCM-PDAC-28

There are no histology images for this model.

Metastasis Information for Model: BCM-PDAC-28

Patient

PDX

Liver

Local

Local recurrence

Lung

Rectum

lymph node

Patient Treatment Information for Model: BCM-PDAC-28

Event Id	Treatment	Treatment Setting	Age at Start	Age at End	Duration	Clinical Response	Pathologic Response	Reason Stopped
20	Gemcitabine/Abraxane with investigational agent (HALO 301)	Adjuvant	59.34	60.53	434 days	Progressive Disease (PD)	No Response (NR)	Stopped due to disease progression and side effects